218 related articles for article (PubMed ID: 12523224)
1. [Beta-thalassemia major in children and adolescents in Denmark].
Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
[TBL] [Abstract][Full Text] [Related]
2. Growth and sexual maturation in children with thalassemia major.
Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
5. Treatment and complications of thalassemia major in Guangxi, Southern China.
Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
[TBL] [Abstract][Full Text] [Related]
6. Intensification of chelating-therapy in patients with thalassemia major.
Laws HJ; Göbel U; Christaras A; Janssen G
Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
[TBL] [Abstract][Full Text] [Related]
7. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
[TBL] [Abstract][Full Text] [Related]
8. Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival.
Pearson HA; Rink L; Guiliotis DK
Conn Med; 1994 May; 58(5):259-60. PubMed ID: 8076456
[TBL] [Abstract][Full Text] [Related]
9. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
[TBL] [Abstract][Full Text] [Related]
10. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
11. [Long-term effects of combined therapy in patients with beta-thalassemia major].
Bagnulo S; Giannini AM; Moscatelli F; Stragapede L; Acquafredda A; Dammacco A
Pediatr Med Chir; 1998; 20(1):33-7. PubMed ID: 9658419
[TBL] [Abstract][Full Text] [Related]
12. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
13. [Therapeuetic management of patients with thalassemia major].
Thuret I
Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
[TBL] [Abstract][Full Text] [Related]
14. Desferrioxamine induced urinary iron excretion in thalassemia.
Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
[TBL] [Abstract][Full Text] [Related]
15. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
Suvarna J; Ingle H; Deshmukh CT
Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
[TBL] [Abstract][Full Text] [Related]
18. Cardiac status in well-treated patients with thalassemia major.
Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
20. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
